🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

525 results for “Teva” Clear

  1. Fremanezumab

    Teva Pharma GmbH

    Migraine Prophylaxis

    phase 3 small molecule completed

    1 trial

  2. Fremanezumab

    Teva Pharma GmbH

    Cluster Headache

    phase 3 small molecule terminated

    1 trial

  3. Fremanezumab

    Teva Pharma GmbH

    Episodic Cluster Headache

    phase 3 small molecule terminated

    1 trial

  4. Fremanezumab

    Teva Pharma GmbH

    Chronic Cluster Headache

    phase 3 small molecule terminated

    1 trial

  5. GA 20 mg/mL

    Teva Pharma GmbH

    Relapsing-Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  6. GABITRIL (tiagabine hydrochloride; CEP-6671)

    Teva Pharma GmbH

    General Anxiety Disorder

    phase 3 small molecule completed

    1 trial

  7. Gabitril

    Teva Pharma GmbH

    Anxiety Disorder

    phase 3 small molecule completed

    1 trial

  8. Gabitril

    Teva Pharma GmbH

    Anxiety Disorders

    phase 3 small molecule completed

    1 trial

  9. Gabitril

    Teva Pharma GmbH

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    2 trials

  10. Gemcitabine Eugia 40 mg/ml solution à diluer pour perfusion, RILVEGOSTOMIG, Cisplatine Teva 1 mg/ml solution à diluer pour perfusion.

    CERO THERAPEUTICS HOLDINGS, INC.

    Hihg risk of cholangiocarcinoma intra hépatic resectable

    phase 3 small molecule active

    1 trial

  11. Generic Budesonide/Formoterol Fumarate Dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  12. Generic Estradiol Vaginal Cream USP, 0.01%

    Teva Pharma GmbH

    Atrophic Vaginitis

    phase 3 small molecule completed

    1 trial

  13. Generic Ivermectin Lotion 0.5%

    Teva Pharma GmbH

    Head Lice

    phase 3 small molecule completed

    1 trial

  14. Glatiramer Acetate

    Teva Pharma GmbH

    Optic Neuritis

    phase 3 small molecule completed

    1 trial

  15. Glatiramer Acetate (DB)

    Teva Pharma GmbH

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  16. Glatiramer Acetate (GA) 40 mg

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  17. Glatiramer Acetate 20 mg/0.5 mL

    Teva Pharma GmbH

    Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  18. Glatiramer acetate (GA)

    Teva Pharma GmbH

    Relapsing Remitting Multiple Sclerosis

    phase 3 small molecule completed

    1 trial

  19. Hydrocodone ER

    Teva Pharma GmbH

    Low Back Pain

    phase 3 small molecule completed

    2 trials

  20. Hydrocodone ER

    Teva Pharma GmbH

    Chronic Pain

    phase 3 small molecule completed

    2 trials

  21. IVEMEND 150 mg powder for solution for infusion, Aprepitant Placebo Tablet, Aprepitant Teva 80 mg, harde capsules, NaCl I.V.

    AXIM BIOTECHNOLOGIES, INC.

    Delayed chemotherapy induced nausea and vomiting (CINV)

    phase 3 small molecule active

    1 trial

  22. Imiquimod Cream, 3.75%

    Teva Pharma GmbH

    Actinic Keratosis

    phase 3 small molecule completed

    1 trial

  23. Kyprolis 60 mg powder for solution for infusion, Kyprolis 30 mg powder for solution for infusion, DARZALEX 1800 mg solution for injection, ENDOXAN omhulde tablet, omhulde tabletten, 50 mg, Cesnicabtagene autoleucel, Kyprolis 10 mg powder for solution for infusion, Dexamethason Teva 4 mg, tabletten, Bortezomib Accord 3.5 mg powder for solution for injection, Empliciti 300 mg powder for concentrate for solution for infusion., Dexamethason Activase 2 mg tabletten, Pomalidomide Accord 4 mg hard capsules, Emplic

    Disc Medicine

    relapsed/refractory multiple myeloma

    phase 3 small molecule active

    1 trial

  24. LI

    Teva Pharma GmbH

    Squamous Cell Carcinoma of the Oral Cavity

    phase 3 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources